术前奈西立肽对二尖瓣手术后肾功能的影响。
Impact of preoperative nesiritide on renal function after mitral valve surgery.
作者信息
Salzberg Sacha P, Emmert Maximillian Y, Vassalotti Joseph, Nandiwada Deepa Rani, Adams David H
机构信息
Department of Cardiothoracic Surgery, Mount Sinai Medical Center, 1190 Fifth Avenue, New York, NY 10029, USA.
出版信息
Heart Surg Forum. 2009 Aug;12(4):E217-8. doi: 10.1532/HSF98.20091025.
Nesiritide, a recombinant B-type natriuretic peptide used for the intravenous treatment of acute decompensated congestive heart failure. Concerns have been raised about the long-term use of nesiritide, but data is scarce regarding its use in acute congestive heart failure and during cardiac surgery. We conducted a retrospective data review to address the safety of nesiritide for pretreatment of patients undergoing mitral valve surgery.
奈西立肽是一种重组B型利钠肽，用于急性失代偿性充血性心力衰竭的静脉治疗。人们对奈西立肽的长期使用提出了担忧，但关于其在急性充血性心力衰竭和心脏手术期间使用的数据却很少。我们进行了一项回顾性数据审查，以探讨奈西立肽用于二尖瓣手术患者预处理的安全性。
Zotero 插件